<b>Contra-indications for statins:</b>
<ul style="margin: 0; padding: 0 0 0 15px;">
	<li>Active liver disease, high alcohol consumption or pregnancy.</li>
    <li>Women with childbearing potential should only use statin if there is reliable contraception.</li>
</ul>

<h3>Recommended doses of statins in adults with CKD</h3>

<table class="statin_dosages">
	<tr>
		<th>Statin</th>
		<th><div class="tooltip2">eGFR<span>estimated glomerular filtration rate</span></div> G1 - G2 (<a href="img/Prognosis of CKD by GFR and albuminuria category.png" target="_blank" style="font-weight: normal">details</a>)</th>
		<th>
			<div class="tooltip2">eGFR<span>estimated glomerular filtration rate</span></div> G3a - G5
			<div class="tooltip2">**<span>incl. dialysis or kidney transplant patients</span></div>
			(<a href="img/Prognosis of CKD by GFR and albuminuria category.png" target="_blank" style="font-weight: normal">details</a>)
		</th>
	</tr>
	<tr>
		<td></td>
		<td><span style="font-size: 14px;">(60 to >=90 ml/min/1.73m&sup2)</span></td>
		<td><span style="font-size: 14px;">(up to 59 ml/min/1.73m&sup2)</span></td>
	</tr>
	<tr>
		<td>Lovastatin</td>
		<td><div class="tooltip2">GP<span>general population</span></div></td>
		<td><div class="tooltip2">nd<span>not done or not studied</span></div></td>
	</tr>
	<tr>
		<td>Fluvastatin</td>
		<td><div class="tooltip2">GP<span>general population</span></div></td>
		<td>80<div class="tooltip2"><sup>1</sup><span>Data based on ALERT.</span></div> mg/d</td>
	</tr>
	<tr>
		<td>Atorvastatin</td>
		<td><div class="tooltip2">GP<span>general population</span></div></td>
		<td>20<div class="tooltip2"><sup>2</sup><span>Data based on 4D.</span></div> mg/d</td>
	</tr>
	<tr>
		<td>Rosuvastatin</td>
		<td><div class="tooltip2">GP<span>general population</span></div></td>
		<td>10<div class="tooltip2"><sup>3</sup><span>Data based on AURORA.</span></div> mg/d</td>
	</tr>
	<tr>
		<td>Simvastatin/Ezetmibe</td>
		<td><div class="tooltip2">GP<span>general population</span></div></td>
		<td>20 / 10<div class="tooltip2"><sup>4</sup><span>Data based on SHARP.</span></div> mg/d</td>
	</tr>
	<tr>
		<td>Pravastatin</td>
		<td><div class="tooltip2">GP<span>general population</span></div></td>
		<td>40 mg/d</td>
	</tr>
	<tr>
		<td>Simvastatin</td>
		<td><div class="tooltip2">GP<span>general population</span></div></td>
		<td>40 mg/d</td>
	</tr>
	<tr>
		<td>Pitavastatin</td>
		<td><div class="tooltip2">GP<span>general population</span></div></td>
		<td>2 mg/d</td>
	</tr>
</table>

<p class="dosage_note">** incl. dialysis or kidney transplant patients.</p>
<p class="dosage_note">All statins may not be available in all countries. Lower doses than those used in major trials of statins in CKD populations may be appropriate in Asian countries. Note that rosuvastatin 40mg daily is not recommended for use in CKD 1-2 non- transplant patients, as it may increase the risk of adverse renal events. Cyclosporin inhibits the metabolism of certain statins resulting in higher blood levels. Data based on <sup>1</sup>ALERT, <sup>2</sup>4D, <sup>3</sup>AURORA, <sup>4</sup>SHARP. Abbreviations: eGFR, estimated glomerular filtration rate; GP, general population; nd, not done or not studied.</p>